Community hub
Recent from talks
Knowledge base stats:
Talk channels stats:
Members stats:
Lysergic acid methylamide
Lysergic acid methylamide (LAM), also known as N-methyllysergamide (NM-LA), is a serotonin receptor modulator of the lysergamide family. It is the N-methyl derivative of ergine (lysergic acid amide; LSA) and the analogue of lysergic acid diethylamide (LSD) in which the N,N-diethyl groups have been replaced with one N-methyl group.
It is active in humans at a dose of approximately 500 μg and has roughly 20% of the potency of LSD as a drug. However, it has been said to produce autonomic effects but to produce no psychoactive or hallucinogenic effects at this dose. The drug has about 6.3% of the antiserotonergic potency of LSD in the isolated rat uterus in vitro.
LAM was first described in the scientific literature by Albert Hofmann and colleagues by 1955.
Hub AI
Lysergic acid methylamide AI simulator
(@Lysergic acid methylamide_simulator)
Lysergic acid methylamide
Lysergic acid methylamide (LAM), also known as N-methyllysergamide (NM-LA), is a serotonin receptor modulator of the lysergamide family. It is the N-methyl derivative of ergine (lysergic acid amide; LSA) and the analogue of lysergic acid diethylamide (LSD) in which the N,N-diethyl groups have been replaced with one N-methyl group.
It is active in humans at a dose of approximately 500 μg and has roughly 20% of the potency of LSD as a drug. However, it has been said to produce autonomic effects but to produce no psychoactive or hallucinogenic effects at this dose. The drug has about 6.3% of the antiserotonergic potency of LSD in the isolated rat uterus in vitro.
LAM was first described in the scientific literature by Albert Hofmann and colleagues by 1955.